Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

25,82 +0,43 (+1,69%) Börsenschluss: 04:10PM AEST

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 6.391

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Lewis G. Gradon	MD, CEO & Executive Director	2,33M	N/A	1961
Ms. Lyndal York	Chief Financial Officer	N/A	N/A	N/A
Andy Niccol	COO & GM of Respiratory Humidification	N/A	N/A	N/A
Dr. Andrew Somervell	Vice President of Products & Technology	N/A	N/A	N/A
Hayden Brown	Head of Capital Markets & Investor Relations	N/A	N/A	N/A
Raelene Leonard	Company Secretary & General Counsel	N/A	N/A	N/A
Daniel Adolph	Senior Communications & Investor Relations Manager	N/A	N/A	N/A
Mr. Justin Callahan	VP of Sales & Marketing and President of North America & Europe	N/A	N/A	N/A
Ms. Nicola Talbot	Vice President of Human Resources	N/A	N/A	N/A
Mr. Jonathan Rhodes	Vice President of Supply Chain, Facilities & Sustainability	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Corporate Governance

Fisher & Paykel Healthcare Corporation Limiteds ISS Governance QualityScore, Stand 29. April 2024, lautet 6. Die grundlegenden Scores sind Audit: 5, Vorstand: 5, Shareholderrechte: 7, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.